What research is being done to prevent EGIDs? There are four stages of disease prevention: Reducing risk factors for all patients. Preventing EGIDs in healthy but susceptible patients. Identifying patients who have early signs of EGIDs without symptoms. Reducing disease severity in patients diagnosed with EGIDs. The increase in EGIDs is likely due to a combination of factors, including specific exposures, patient characteristics, and the environment. Potential early life exposures may include prematurity, caesarean section delivery, lack of breastfeeding, and acid blocker or antibiotic use in infancy. Patient factors include other allergic diseases, poor oesophageal barrier function, and increased susceptibility to inflammation and scarring. Potential environmental factors include cold, arid climates. Future studies are needed to identify cause-and-effect relationships between these factors and the development of EGIDs. Information is provided by The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Learn more about CEGIRs work Donate today for a brighter tomorrow Last updated 18/7/23 ©EOS Network 2023 All rights reserved Manage Cookie Preferences